TruBridge, Inc. Stock Hits New 52-Week Low at $14.67

TruBridge, Inc., a microcap player in the healthcare services industry, has reached a new 52-week low of USD 14.67 as of March 24, 2026. This significant decline highlights the stock's recent performance, contrasting sharply with its 52-week high of USD 29.78. Over the past year, TruBridge has demonstrated a performance increase of 52.36%, significantly outpacing the S&P 500's growth of 13.68%. The company's market capitalization stands at USD 266 million, reflecting its position within the microcap segment. Financial metrics indicate a price-to-earnings (P/E) ratio of 24.00, while the return on equity is reported at 6.15%. The company's debt-to-equity ratio is 0.81, suggesting a moderate level of leverage. Additionally, TruBridge does not offer a dividend yield, which is consistent with many companies in the microcap space focusing on growth reinvestment. As the stock navigates these fluctuations, its performance metrics will be closely monitored by market participants.